Many seniors ready to shrink their lists of prescription drugs, survey reveals
By
Alicia Lasek (f3)
Jun 07, 2022
Many older adults say they are motivated to cut down on their prescription medications to avoid future side effects — if their physician suggests they do so.
New FDA initiative seeks to boost clinicians’ dietary supplements knowledge
By
Alicia Lasek (f3)
Jun 03, 2022
Educational supports for healthcare providers include a continuing education program on the benefits and risks of dietary supplements.
Tweet personal stories to reduce patients’ vaccine hesitancy, study suggests
By
Alicia Lasek (f3)
Jun 13, 2022
Patients may be more likely to be vaccinated against COVID-19 when clinicians share personal vaccination stories on social media, investigators contend.
Community burden of dementia symptoms mirrors that of nursing homes, caregiver survey finds
By
Alicia Lasek (f3)
Apr 29, 2022
Frequent, unsubtle symptoms have a big impact on patient quality of life, but are often unreported in primary care, investigators report.
Vaccine to protect seniors from RSV ready for FDA review, drugmaker says
By
Alicia Lasek (f3)
Jun 13, 2022
A vaccine to help prevent a leading cause of pneumonia in the elderly has been found effective in late-stage clinical trials.
White House urges greater use of Paxlovid as supply increases
By
Alicia Lasek (f3)
Apr 28, 2022
Health officials are encouraging physicians to more frequently consider prescribing the oral antiviral now that it is no longer in short supply.
Paxlovid keeping hospitalizations, deaths low as COVID-19 infections rise, White House official says
By
Alicia Lasek (f3)
May 19, 2022
Clinicians are writing 20,000 prescriptions for Paxlovid each day, helping to keep severe outcomes in check, the COVID-19 Response Coordinator said Wednesday.
F-tags study reveals common misuses of psychotropic drugs in LTC
By
Alicia Lasek (f3)
May 13, 2022
A study of deficiency-of-care citations in nursing homes offers lessons on reducing over-reliance on psychotropics in residents with dementia, investigators say.
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Fall vaccination campaign could avert 160,000 U.S. deaths, analysts project
By
Alicia Lasek (f3)
Jul 27, 2022
Fully 160,000 deaths and 1.7 million hospitalizations could be averted if 80% of the eligible U.S. population received COVID-19 booster doses this fall, the Commonwealth Fund estimates in a new report.